Clarity Pharmaceuticals
Latest round
- Seed
Last raised
- May 2014
Total raised
- $2.6M
Investors
- 6
About Clarity Pharmaceuticals
Founded in 2010 in Sydney, Australia, Clarity Pharmaceuticals develops innovative radiopharmaceutical products.Clarity Pharmaceuticals specializes in developing advanced radiopharmaceutical products that leverage its proprietary SAR Technology platform. Its primary offerings include SAR-bisPSMA, SAR-Bombesin, and SARTATE, each designed to deliver targeted therapy and diagnostic capabilities for various cancers. SAR-bisPSMA targets prostate cancer as both a diagnostic and treatment option, SAR-Bombesin serves as a pan-cancer theranostic applicable to multiple cancer types, and SARTATE targets neuroblastoma and neuroendocrine tumors, addressing significant unmet clinical needs.Clarity Pharmaceuticals generates revenue through partnerships and collaborations with healthcare institutions and research organizations in oncology. The revenue model is centered on the clinical development and commercialization of its flagship products, which are sold directly to hospitals and clinics. Revenue streams include upfront payments upon entering partnership agreements and milestone payments tied to clinical trial progress and regulatory approvals. Once launched, sales may occur through B2B transactions with established distribution channels in the oncology market. The company is focused on designing and launching additional radiopharmaceuticals to address various cancers, with specific timelines for product launches to be announced. Furthermore, Clarity aims to enter new markets in Europe and Asia-Pacific by 2024, enhancing its global footprint.
Who invested in Clarity Pharmaceuticals
6 investors across 2 rounds
See all investors in Clarity Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Clarity Pharmaceuticals
Who invested in Clarity Pharmaceuticals?
Clarity Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clarity Pharmaceuticals raised?
Clarity Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Clarity Pharmaceuticals last raise money?
Clarity Pharmaceuticals's most recent round on record is a Seed, in May 2014.
What does Clarity Pharmaceuticals do?
Founded in 2010 in Sydney, Australia, Clarity Pharmaceuticals develops innovative radiopharmaceutical products.
Where is Clarity Pharmaceuticals headquartered?
Clarity Pharmaceuticals is headquartered in Sydney, Australia.
Which VCs invest in companies like Clarity Pharmaceuticals?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back pharmaceuticals companies at Clarity Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Clarity Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.